How much funding has Foghorn Therapeutics raised?

Foghorn Therapeutics has raised $296.0M in total funding, most recently a Corporate Round.

When was Foghorn Therapeutics founded?

Foghorn Therapeutics was founded in 2016.

Where is Foghorn Therapeutics headquartered?

Foghorn Therapeutics is headquartered in Watertown, Massachusetts, United States.

What industry is Foghorn Therapeutics in?

Foghorn Therapeutics operates in Biotech, Healthcare.

How many employees does Foghorn Therapeutics have?

Foghorn Therapeutics has 51-200 employees.

Foghorn Therapeutics

IPO

Public · Watertown, United States · Founded 2016 · $296.0M raised

Biotech

Healthcare

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B
Website: foghorntx.com

Total Funding: $296.0M
Last Round: $110.0M Corporate RoundJan 2026
Rounds: 3
Type: Public

About

Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Using its Gene Traffic Control® platform, the company identifies and validates targets to develop precision therapies for cancer and other serious diseases. Its lead programs include selective inhibitors and degraders targeting SMARCA2 and CBP/EP300. Headquartered in Watertown, Massachusetts.

Summary

Foghorn Therapeutics is a Biotech company based in Watertown, United States, founded in 2016. It has raised $296.0M in total across 3 rounds, most recently a $110.0M Corporate Round round in Jan 2026.

LinkedIn X (Twitter)